REG - Sopheon PLC - Issue of Equity

SopheonAnnouncement

08/01/2024 12:30

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240108:nRSH9775Ya&default-theme=true

RNS Number : 9775Y  Sopheon PLC  08 January 2024

 
SOPHEON PLC

("Sopheon" or the "Company")

 

Issue of Equity

 

Sopheon, the InnovationOps software company, announces that following the
exercise of options by a former employee it has allotted 13,726 new Ordinary
Shares of 20 pence each in the Company ("Ordinary Shares").

 

Application will be made for the new Ordinary Shares to be admitted to trading
on AIM and dealings are expected to commence on 12 January 2024.

 

The new Ordinary Shares will rank pari passu with the Company's existing
Ordinary Shares. The total number of Ordinary Shares in issue following
Admission will be 10,706,805. The Company does not hold any shares in
treasury. Accordingly, the figure of 10,706,805 may be used by shareholders as
the denominator for the calculations by which they will determine if they are
required to notify their interest in, or a change to their interest in the
Company under the FCA's Disclosure Guidance and Transparency Rules.

 

In accordance with Rule 2.9 of the City Code on Takeovers and Mergers (the
"Code"), the Company confirms, pursuant to the exercise of options that there
are currently 10,706,805 new Ordinary Shares of 20 pence each in issue in the
Company and the International Securities Identification Number for Sopheon's
Ordinary Shares is GB00BSZM136.

 

 

For further information contact:

 Andy Michuda (Executive Chairman)                                           Sopheon plc                    + 44 (0) 1276 919 560

Arif Karimjee (CFO)
 Carl Holmes/Abigail Kelly / George Dollemore (Corporate Finance) Sunila de  Cavendish Capital Markets Ltd  + 44 (0) 20 7220 0500
 Silva (ECM)

 

About Sopheon. Sopheon (LSE: SPE) empowers organizations to change the world
while achieving exceptional long-term revenue growth and profitability. By
operationalizing the entire innovation life cycle, Accolade® and Acclaim™
software and expertise enable innovation, product and project professionals to
accomplish the full range of InnovationOps tasks to drive innovation at scale.
Sopheon's industry leadership was highlighted in the comprehensive
MarketsandMarkets™ report on the Innovation Management market, in which
Sopheon was listed in the "Stars" category, the highest recognition. Sopheon's
solutions have been implemented by hundreds of blue-chip customers with over
125,000 users in 50 countries. Sopheon is listed on the AIM Market of the
London Stock Exchange. For more information, please visit www.sopheon.com
(http://www.sopheon.com) .

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  IOEBDGDBBDGDGSI